The principle of a threshold dose in chemical carcinogenesis

Food Additives and Contaminants
C Frayssinet

Abstract

The nature of at least three stages in carcinogenesis by chemical agents justifies the existence of a threshold dose: (1) a cytoplasmic stage during which most carcinogenic molecules are eliminated, (2) a nuclear stage during which certain DNA lesions are repaired and therefore cannot help to bring about mutations, and (3) an extracellular stage during which mutations are controlled for a long time by positive or negative epigenetic factors. All these findings are very difficult to collate. Since threshold doses cannot be detected by direct experimentation, the knowledge that a threshold exists is of little practical use and does not much alter the data permitting extrapolation of the results obtained with high doses of carcinogens. At the theoretical level only, this conclusion renders obsolete the opinion that all carcinogenic agents should be completely eliminated from our environment, and also the view that DNA needs only one hit from such an agent for a carcinogenic effect to be produced. The above conclusion also provides a more rational basis for the concept of a 'virtually safe dose' (VSD) or 'allowable daily intake' (ADI).

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.